Dr. Foods, Inc. (DRFS) Financial Statements (2024 and earlier)

Company Profile

Business Address 3F K MINAMIAOYAMA
TOKYO, 107-0062
State of Incorp. NV
Fiscal Year End March 31
Industry (SIC) 677 - Blank Checks (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
3/31/2022
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments82,2951,3659,67844,376200,802 
Cash and cash equivalents82,2951,3659,67844,376200,802 
Receivables2,1693846,1643,091  
Advances on inventory purchases  567    
Other undisclosed current assets601,894539,862572,720552,448512,145 
Total current assets:686,358542,178588,562599,915712,947 
Noncurrent Assets
Deferred income tax assets 288,684270,030253,285232,134 
Other undisclosed noncurrent assets (288,684)(270,030)(253,285)(232,134) 
TOTAL ASSETS:686,358542,178588,562599,915712,947 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,56010,1014,9964,5784,0247,000
Accounts payable4,5607,3964,9964,5784,024 
Accrued liabilities  2,705   7,000
Due to related parties29,52413,024   
Other liabilities194497566443  
Total current liabilities:4,75440,12218,5865,0214,0247,000
Noncurrent Liabilities
Other undisclosed liabilities83,476     
Total liabilities:88,23040,12218,5865,0214,0247,000
Equity
Equity, attributable to parent, including:598,128502,056569,976594,894708,923(7,000)
Preferred stock111111
Common stock1,3711,3121,3121,312262,297231,528
Additional paid in capital2,108,6011,899,1141,876,0041,868,0041,587,306814,339
Accumulated deficit(1,443,050)(1,374,688)(1,285,856)(1,206,118)(1,105,399)(1,052,868)
Other undisclosed equity, attributable to parent(68,795)(23,683)(21,485)(68,305)(35,282) 
Total equity:598,128502,056569,976594,894708,923(7,000)
TOTAL LIABILITIES AND EQUITY:686,358542,178588,562599,915712,947 

Income Statement (P&L) (USD)

9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
3/31/2022
Q4
Revenues616846154   
Other undisclosed gross profit  2513   
Gross profit:616871167   
Operating expenses(70,293)(87,660)(82,900)(103,333)(52,531)(12,438)
Operating loss:(69,677)(86,789)(82,733)(103,333)(52,531)(12,438)
Loss from continuing operations before income taxes:(69,677)(86,789)(82,733)(103,333)(52,531)(12,438)
Income tax expense (benefit) 304(8)478  
Loss from continuing operations:(69,677)(86,485)(82,741)(102,855)(52,531)(12,438)
Loss before gain (loss) on sale of properties:(102,855)(52,531)(12,438)
Net loss:(69,677)(86,485)(82,741)(102,855)(52,531)(12,438)
Other undisclosed net income (loss) attributable to parent1,315(2,347)3,0032,136  
Net loss available to common stockholders, diluted:(68,362)(88,832)(79,738)(100,719)(52,531)(12,438)

Comprehensive Income (USD)

9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
3/31/2022
Q4
Net loss:(69,677)(86,485)(82,741)(102,855)(52,531)(12,438)
Comprehensive loss, net of tax, attributable to parent:(69,677)(86,485)(82,741)(102,855)(52,531)(12,438)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: